Join Health Foundry for an exciting introductory session to productising healthtech!
Posted:
Lunch&Learn: Productising HealthTech
Mon, 19 April 2021, Online
13:30 – 14:30 CEST
Clinical need should be paramount, but without effective productisation, your solution can't be bought or used.
This session unpacks some of the key issues and decisions faced in turning HealthTech solutions into products. Productisation decisions are difficult because they force standardisation and remove customer choice. Counterintuitively, it's this reduction in choice which enables scale delivery.
The Bacillus Calmette-Guérin (BCG) vaccine prevents severe forms of tuberculosis (TB) and is the world’s most widely used vaccine, as well as the oldest vaccine still in use.
Read more here.
Cigna's Evernorth is investing $100 million through 2028 in specialty pharmacy care.
The AI program called Pharmacy Forward is expected to generate approximately $400 million in value by the end of 2028, according to Evernorth.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us